We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $228.6 · 20 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Is It Too Late To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)? - Yahoo Finance
Is It Too Late To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)? Yahoo Finance
CNIL fines IQVIA €5M for health data warehouse breaches - PPC Land
CNIL fines IQVIA €5M for health data warehouse breaches PPC Land
Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise? - Zacks Investment Research
Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise? Zacks Investment Research
IQVIA Rose 6% This Week. Here’s How Much the Stock Could Rise in 2026 - TIKR.com
IQVIA Rose 6% This Week. Here’s How Much the Stock Could Rise in 2026 TIKR.com
IQVIA Holdings Inc (IQV) Stock Up 9.3% and Still Undervalued -- GF Score: 84/100 - GuruFocus
IQVIA Holdings Inc (IQV) Stock Up 9.3% and Still Undervalued -- GF Score: 84/100 GuruFocus
IQVIA jumps 9.3% as investors refocus on raised 2026 profit outlook and buyback support - Quiver Quantitative
IQVIA jumps 9.3% as investors refocus on raised 2026 profit outlook and buyback support Quiver Quantitative
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 21. | After market close (AMC) | $3.03 | — | — | $4.31B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $1.4 | — | — | $3.83B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $5.08 | — | — | $11.45B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $3.53 | — | — | $7.55B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 09. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
| 2026. 03. 10. | TD Cowen | — | Upgrade | Hold → Buy | — | TD Cowen: Hold → Buy |
| 2026. 03. 06. | Barclays | — | Upgrade | Equal-Weight → Overweight | — | Barclays: Equal-Weight → Overweight |
| 2026. 03. 04. | RBC Capital | — | Initiate coverage | — → Outperform | — | RBC Capital: Outperform |
| 2026. 02. 20. | Truist Securities | — | Maintain | Buy → Buy | — | Truist Securities: Buy |
| 2026. 02. 07. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.